DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Adderall XR ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
13
多発性硬化症/視神経脊髄炎
2
13. 多発性硬化症/視神経脊髄炎
臨床試験数
:
3,342
/
薬物数
:
2,355
- (
DrugBank
:
406
) /
標的遺伝子数
:
269
-
標的パスウェイ数
:
241
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT02676739
(
ClinicalTrials.gov
)
May 20, 2016
3/2/2016
Adderall XR
and Cognitive Impairment in MS
A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (
Adderall XR
) for Cognitive Impairment in MS
A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (
Adderall XR
) f ...
Multiple Sclerosis
Drug:
Adderall XR
Sarah Morrow
NULL
Recruiting
18 Years
59 Years
All
180
Phase 2/Phase 3
Canada
2
NCT01667484
(
ClinicalTrials.gov
)
September 2012
13/8/2012
Adderall XR
and Processing Speed in Multiple Sclerosis (MS)
Does
Adderall XR
Improve Processing Speed in Cognitively Impaired MS Patients?
Impaired Processing Speed;Cognitive Impairment;Multiple Sclerosis
Drug:
Adderall XR
5mg;Drug:
Adderall XR
10 mg;Drug: Placebo
London Health Sciences Centre
NULL
Completed
18 Years
59 Years
Both
70
Phase 2/Phase 3
Canada